MIGUEL ÁNGEL
TEJADA GIRÁLDEZ
PROGRAMA JUAN DE LA CIERVA
Boston Children's Hospital
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Boston Children's Hospital (2)
2022
-
Phenotypic drug screen uncovers the metabolic GCH1/BH4 pathway as key regulator of EGFR/KRAS-mediated neuropathic pain and lung cancer
Science Translational Medicine, Vol. 14, Núm. 660
2018
-
Targeting immune-driven opioid analgesia by sigma-1 receptors: Opening the door to novel perspectives for the analgesic use of sigma-1 antagonists
Pharmacological Research, Vol. 131, pp. 224-230